A novel embryonic poly(A) binding protein, ePAB, regulates mRNA deadenylation in Xenopus egg extracts

  1. Gia K. Voeltz1,
  2. Julina Ongkasuwan1,
  3. Nancy Standart2, and
  4. Joan A. Steitz1,3
  1. 1Department of Molecular Biophysics and Biochemistry, Yale University, Howard Hughes Medical Institute, New Haven, Connecticut 06536, USA; 2Department of Biochemistry, University of Cambridge, Cambridge CB2 1GA, UK

Abstract

An in vitro system that recapitulates the in vivo effect of AU-rich elements (AREs) on mRNA deadenylation has been developed fromXenopus activated egg extracts. ARE-mediated deadenylation is uncoupled from mRNA body decay, and the rate of deadenylation increases with the number of tandem AUUUAs. A novel ARE-binding protein called ePAB (for embryonicpoly(A)-binding protein) has been purified from this extract by ARE affinity selection. ePAB exhibits 72% identity to mammalian and Xenopus PABP1 and is the predominant poly(A)-binding protein expressed in the stage VI oocyte and during Xenopus early development. Immunodepletion of ePAB increases the rate of both ARE-mediated and default deadenylation in vitro. In contrast, addition of even a small excess of ePAB inhibits deadenylation, demonstrating that the ePAB concentration is critical for determining the rate of ARE-mediated deadenylation. These data argue that ePAB is the poly(A)-binding protein responsible for stabilization of poly(A) tails and is thus a potential regulator of mRNA deadenylation and translation during early development.

Keywords

Footnotes

  • 3 Corresponding author.

  • E-MAIL joan.steitz{at}yale.edu; FAX (203) 624-8213.

  • Article and publication are at www.genesdev.org/cgi/doi/10.1101/gad.872201.

    • Received December 7, 2000.
    • Accepted January 26, 2001.
| Table of Contents

Life Science Alliance